Anticoagulants and antiplatelets around procedures
- Treatment and support
Stopping a blood thinner for surgery risks a stroke or clot; continuing it risks bleeding. The skill is weighing the two for each patient and procedure.
What it is
Perioperative management of antithrombotic drugs balances two risks: bleeding from the procedure and clotting while the drug is off. Many minor procedures can be done without interruption. When a drug must be stopped, how long before depends on how fast it wears off and on kidney function. Bridging means covering the gap left by warfarin with a short-acting heparin; it is reserved for patients at the highest risk of clotting, because it adds bleeding. Direct oral anticoagulants wear off quickly and are not bridged. Antiplatelets after a recent coronary stent are a special case decided with the cardiologist.
What to know
- Low-bleeding-risk procedures (most dental extractions, cataract, skin surgery, diagnostic endoscopy) are often done without stopping the anticoagulant, using local haemostasis.
- Warfarin takes several days to wear off; the INR is checked before surgery, and vitamin K can correct a still-high value.
- Bridging with heparin is for the highest thrombotic risk: mechanical mitral or older-design valves, a stroke or venous clot in recent months, or a severe thrombophilia.
- In atrial fibrillation, routine bridging of warfarin increased bleeding without reducing stroke in a randomised trial, so most patients are not bridged.
- Direct oral anticoagulants are stopped for a period set by the drug, the kidney function (dabigatran depends most on the kidneys) and the bleeding risk; they are not bridged.
- Aspirin is usually continued, except in closed-space surgery such as neurosurgery or some spinal, eye and urological operations.
- After a coronary stent, stopping dual antiplatelet therapy early can cause stent thrombosis; elective surgery is postponed until the minimum course is complete.
How it is done (and why)
- Ask: what drug, why it was started, when the last dose was, and how well the kidneys work.
- Grade the procedure's bleeding risk; if low, plan to continue the drug with local haemostasis.
- Grade the patient's clotting risk while off the drug (valve type, recent clot or stroke, thrombophilia, cancer).
- If the drug must stop: time the last dose by its half-life and kidney function, using the local protocol.
- Bridge only warfarin and only in the highest clotting risk; DOACs and antiplatelets are not bridged.
- Neuraxial anaesthesia has its own stop and restart intervals (see the anaesthesia page).
- Restart once haemostasis is secure: DOACs act within hours, so restart later after high-bleeding-risk surgery; give clot prophylaxis meanwhile.
How each drug class is handled around a procedure
| Drug class | How it wears off | Bridging? | Check before | Restart |
|---|---|---|---|---|
| Warfarin | Slowly, over days, as factors are remade | Only in the highest clotting risk | INR; vitamin K if still high | When bleeding is controlled; heparin cover until the INR is in range if bridged |
| DOACs (apixaban, rivaroxaban, edoxaban, dabigatran) | Quickly, within days; longer with poor kidney function | No | Kidney function; drug level only if urgent | Full effect within hours: delay after high-bleeding-risk surgery |
| Low-molecular-weight heparin | Within about a day; cleared by the kidneys | It is the usual bridge | Kidney function, platelets | Prophylactic level first, full level once haemostasis is secure |
| Aspirin | Platelets stay blocked for their lifespan | No | Why it is taken (stent, stroke, primary prevention) | Usually continued (always with a stent or for secondary prevention); may be stopped for primary prevention or closed-space surgery; restart early if stopped |
| P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel) | Several days, as new platelets are made | No (specialist plans only) | Date and type of stent; cardiology opinion | As soon as bleeding allows, especially after a stent |
Risks and precautions
- The commonest harm is not bleeding but an unnecessary stop: a patient told to stop an anticoagulant for a minor procedure who then has a stroke.
- A patient with a drug-eluting coronary stent placed recently who needs urgent surgery keeps aspirin and is discussed with cardiology before the P2Y12 inhibitor is stopped.
- Emergency surgery on an anticoagulant is a reversal problem, not a bridging one: see the page on bleeding on anticoagulants.
- Write the plan down with dates: last dose, any bridge, restart, and who to call; most errors happen at handovers.
Monitoring and next step
- Kidney function before every DOAC or heparin plan, because it changes how long the drug lasts.
- INR before surgery on warfarin; correct a high value with vitamin K if time allows.
- Platelet count before and during heparin bridging, watching for heparin-induced thrombocytopenia.
- Urgent surgery on a DOAC: a drug-specific level (calibrated anti-Xa or dilute thrombin time), as the laboratory offers.
- After surgery: haemoglobin and wound checks before the full anticoagulant level is resumed.
Common traps
- Bridging every patient who stops warfarin: in most atrial fibrillation it adds bleeding without preventing strokes
- Bridging a DOAC with heparin: DOACs wear off and come back quickly, so a bridge only adds overlap and bleeding
- Stopping all antiplatelets after a recent coronary stent for elective surgery: stent thrombosis is often fatal, so the surgery is postponed or cardiology decides
- Using one fixed stop time for dabigatran in every patient: it is cleared by the kidneys, so poor renal function needs a longer stop
- Restarting a full anticoagulant level the evening after major surgery: full effect arrives within hours and can turn a dry wound into a haematoma
Test yourself
Think of the answer, then tap the question to see it.
A 72-year-old on apixaban for atrial fibrillation needs a hip replacement. Should he be bridged with heparin, and why?
No: apixaban wears off and acts again within hours, so it is simply stopped for a period set by kidney function and bleeding risk, then restarted once haemostasis is secure.
A woman with a mechanical mitral valve on warfarin needs a colectomy. Which plan fits best?
Stop warfarin and bridge with heparin: a mechanical mitral valve is among the highest clotting risks, so the gap without anticoagulation must be covered.
A man had a drug-eluting coronary stent placed two months ago and is booked for an elective hernia repair. What next?
Postpone the elective surgery and discuss with cardiology: stopping dual antiplatelet therapy this early risks stent thrombosis.
Why does dabigatran need a longer stop before surgery than apixaban in a patient with poor kidney function?
Dabigatran is cleared mostly by the kidneys, so its effect lasts much longer when they work poorly; apixaban depends less on them.
Elsewhere in DurgiPedia
- Anticoagulants, antiplatelets and neuraxial blocks
- Anticoagulants and antiplatelets before dental extraction
- Patients on anticoagulants: bleeding watch, monitoring tests, interactions and teaching
- Preoperative care: assessment, teaching, fasting, skin preparation and the checklist
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Update in Perioperative Ischemic Workup: Integrating 2024 AHA/ACC Guidelines and Contemporary Evidence (Journal of Cardiovascular Development and Disease (Europe PMC open access), 2026); Perioperative Anticoagulation Management (StatPearls (NCBI Bookshelf), 2023); Antiplatelet Medications (StatPearls (NCBI Bookshelf), 2022).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
